Posted by Michael Wonder on 14 Dec 2023
CMS releases revised guidance for Medicare prescription drug inflation rebate program
14 December 2023 - Under President Biden’s lower cost prescription drug law, drug companies will pay rebates to Medicare for raising prescription drug prices faster than the rate of inflation.
As a result of President Biden’s historic prescription drug law, the Inflation Reduction Act, drug companies will pay rebates to Medicare when prices of certain prescription drugs administered or dispensed to people with Medicare increase faster than the rate of inflation. In addition, people with Medicare may pay a lower coinsurance for some Part B drugs if the drugs’ prices increase faster than the rate of inflation.
